Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,446 | 89,159 | 0 | N/A | N/A |
| Marketable Securities | 215,154 | N/A | 0 | N/A | N/A |
| TOTAL | $296,697 | $89,999 | $0 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,981 | 2,241 | 0 | N/A | N/A |
| Other Non-Current Assets | 319 | 1,853 | 0 | 0 | 0 |
| TOTAL | $2,300 | $4,094 | $N/A | $N/A | $N/A |
| Total Assets | $298,997 | $94,093 | $0 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 757 | 152 | 0 | 0 | 0 |
| TOTAL | $9,002 | $5,354 | $0 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 219 | 178,058 | 0 | 0 | 0 |
| TOTAL | $219 | $178,823 | $N/A | $N/A | $N/A |
| Total Liabilities | $9,221 | $184,177 | $0 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,695 | N/A | N/A | N/A | N/A |
| Common Shares | 4 | N/A | 0 | N/A | N/A |
| Retained earnings | -166,393 | -92,690 | 0 | N/A | N/A |
| Other shareholders' equity | -31 | 0 | 0 | 0 | 0 |
| TOTAL | $289,776 | $-90,084 | $0 | $N/A | $N/A |
| Total Liabilities And Equity | $298,997 | $94,093 | $0 | $0 | $0 |